EMA CHMP recommends AstraZeneca-Merck's Lynparza for breast cancer
The EMA CHMP has recommended granting approval for AstraZeneca and Merck’s Lynparza (olaparib) for high-risk early breast cancer patients.
Stay updated with breaking news from Vacuum Drying. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The EMA CHMP has recommended granting approval for AstraZeneca and Merck’s Lynparza (olaparib) for high-risk early breast cancer patients.
Conventional analgesics prescribed for osteoarthritis offer inadequate pain relief and are associated with several adverse events.
The global Covid death toll has passed 5.9 million, with a figure of 5,981,137 according to researchers at Johns Hopkins University.
Massachusetts General Hospital (MGH) and BWH researchers have identified a drug candidate, larazotide acetate, to treat MIS-C in children.
The University of Oxford has announced the launch of a partnership to analyse the repurposing of existing anti-viral drugs for Covid-19.